Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06097182
Other study ID # 2023-086
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 2023
Est. completion date September 2024

Study information

Verified date October 2023
Source Singapore Institute for Clinical Sciences
Contact Jeroen Schmitt, PhD
Phone 6407 4060
Email jeroen_schmitt@sics.a-star.edu.sg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to evaluate the sub-chronic effects of colonic delivery of a postbiotic on stress response, mood state, sleep, and cognition in healthy young subjects with elevated self-reported stress levels. It is hypothesized that oral intake of the postbiotic, when released in the colonic intestinal site, leads to a blunted subjective and objective stress response after a stress induction.


Description:

Scientific findings over the past years suggest that certain bacteria in our gastrointestinal system have an influence on our mood, although, the mechanisms are not yet well understood. One of the possibilities is that bacteria produce compounds that interact with neurons in the gut. These neurons could subsequently send signals to the brain. This study is a proof of principle study examining the effects of a postbiotic in the distal intestinal tract (terminal ileum, colon) on stress response, mood state, sleep, and cognition. The study is expected to provide key insights in the potential of treatment strategies aimed at stimulating the colonic enteric nervous system to exert mood enhancement. It is hypothesized that interactions with the local Enteric Nervous System leading to stress reduction, mood enhancement and sleep promotion effects. The study will employ an in-person clinic visit, in addition to traditional self-reported, behavioural, and physiological outcome measures; exploratory digital health outcomes will also be included to identify novel objective mood/stress measures. This study seeks to recruit a total of 75 healthy males (25 in each arm), between the ages of 21-30 years old (inclusive) from local community outreach in Singapore over a period 12 months. This study is a hybrid study (partially decentralized). The total duration of participation from each participant will be 9 days (excluding, the screening and enrolment days).


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date September 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 21 Years to 30 Years
Eligibility Inclusion Criteria: - Aged 21 to 30 years - Men - Perceived Stress Scale (PSS-10) score >13 - Own and uses a smartphone that is capable to run the study applications with access to the internet - Adequate fluency in the English language to understand the inform consent process, study instructions and study assessments - Sufficient vision and hearing to complete study procedures - Willing to commit to the study procedures - Willing and able to participate and to give written informed consent All inclusion criteria will be assessed based on self-reported information during the screening visit. Exclusion Criteria: - Past (< 6 months prior to the study) or current major neurological, psychiatric, gastrointestinal, metabolic disease or cardiovascular disease - Past (<1 months prior to the study) or current use of psychoactive medication, cardiovascular medication, or corticosteroids. - Known medical history of hypotension or currently on antihypertensive medication - Alcohol intake >1 units day - Present or past history of alcohol or drug addiction and/or recreational drug use - BMI <18.5 or >25 kg/m2 - Maltodextrin allergy - Members of the research team or their immediate family members. An immediate family member is defined as spouse, parent, child, or sibling, whether biological or legally adopted All exclusion criteria will be assessed based on self-reported information during the screening call.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Postbiotic (Colonic-Delivery capsule)
250mg postbiotic once daily in a polymer coated vegan gelatine capsule (colonic delivery)
Postbiotic (Regular Administration capsule)
250mg postbiotic once daily in a regular uncoated vegan gelatine capsule
Other:
Placebo
250mg Maltodextrin once daily in a regular uncoated vegan gelatine capsule

Locations

Country Name City State
Singapore Human Development Research Centre, SICS, A*STAR Singapore

Sponsors (1)

Lead Sponsor Collaborator
Singapore Institute for Clinical Sciences

Country where clinical trial is conducted

Singapore, 

References & Publications (1)

Boets E, Gomand SV, Deroover L, Preston T, Vermeulen K, De Preter V, Hamer HM, Van den Mooter G, De Vuyst L, Courtin CM, Annaert P, Delcour JA, Verbeke KA. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. J Physiol. 2017 Jan 15;595(2):541-555. doi: 10.1113/JP272613. Epub 2016 Sep 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Ecological Momentary Assessments (EMA) Subjects are asked to indicate their current state on a visual analogue scale ranging from 'not at all' to 'very much' using a slider. Day 1-6 (4/day), Day 7 (2/day), Day 8 (1/day)
Other Salivary a-amylase a-amylase levels, as a marker of autonomic nervous system activation Day 7 (5/day)
Other Gastrointestinal Symptoms Participants will be asked to rate the average severity of the following five symptoms over the preceding 24 hours on a 5-point scale from 0 (absent) to 4 (very severe): bloating/distension, passage of gas, rumbling, feeling of fullness and abdominal discomfort/pain. A daily total score is calculated by summing all items recorded each day. A lower score is concomitant with lower severity of symptoms. Days 1-7 (1/day)
Other Respiratory Rate Measured as how many breaths per minute. Continuous monitoring via a smartwatch. Days 1-7
Other Electrodermal Activity (EDA) 4 user-initiated 2 min sessions per day. Measured via a smartwatch and the total score per session is provided by the watch. Days 1-7
Other Speech Analysis for digital stress biomarkers Subjects are requested to verbally reproduce an orally presented standard short story from Newcomer Story Set. A high-resolution video with audio will be recorded and exploratory analyses of speech characteristics will be performed. Day 7 (2/day)
Other Eye Movement Analysis for digital stress biomarkers Subjects are requested to verbally reproduce an orally presented standard short story from Newcomer Story Set. A high-resolution video with audio will be recorded and exploratory analyses of eye movements will be performed. Day 7 (2/day)
Other Facial Expression Analysis for digital stress biomarkers Subjects are requested to verbally reproduce an orally presented standard short story from the Newcomer Story Set. A high-resolution video with audio will be recorded and exploratory analyses of facial characteristics will be performed. Day 7 (2/day)
Other Handwriting Analysis for digital stress biomarkers Subjects are requested to write down words of a specific category with a specified starting letter. As an exploratory outcome, a digital picture of the written text will be analyzed for handwriting characteristics such as trace, calibre, slant, and distance. Day 7 (2/day)
Other Cognitive performance Cognitive performance will be assessed with a short (5 min) test battery consisting of tests of processing speed, spatial memory, and reaction time delivered through a mobile application that was developed to assess individuals' cognition in natural, non-laboratory, settings. Days 1-8
Primary Salivary Cortisol cortisol levels, as a marker of hypothalamic-pituitary-adrenal (HPA) axis activation Day 7 (5/day)
Secondary State Trait Anxiety Inventory (STAI-6) The STAI-6 is a validated short-form version (6 items) of the 40-item STAI questionnaire, measuring current anxiety symptoms on a 4-point Likert scale. Total score is calculated (range 6-24). Day 7 (2/day)
Secondary The Brunel Mood Scale (BRUMS) The BRUMS is a 24-item questionnaire of simple mood descriptors such as angry, nervous, unhappy, and energetic. The BRUMS has six subscales, with each of the subscales containing four mood descriptors. The subscales are anger, confusion, depression, fatigue, tension, and vigour. Responses are recorded using a 5-point Likert scale (0-4). Day 7 (2/day)
Secondary Heart Rate Measured as beats per minute. Continuous monitoring via a smartwatch. Days 1-7
Secondary Sleep Activity During sleep, the activity will be monitored via a smartwatch throughout the sleep session. Days 1-7
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT04513743 - Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ N/A
Completed NCT03251274 - Bath Machine on Sleep Quality in Nursing Home N/A
Completed NCT04102345 - Lavender vs Zolpidem Sleep Quality During Diagnostic PSG Early Phase 1
Completed NCT03725943 - Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT04562181 - Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index N/A
Completed NCT05576844 - Ai Youmian (Love Better Sleep) for People Living With HIV N/A
Completed NCT05102565 - A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers N/A
Completed NCT04688099 - Synovial Fluid Sleep Study
Recruiting NCT04171245 - Prescribing Laughter for Sleep and Wellbeing in UAE University Students N/A
Completed NCT03758768 - The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms N/A
Completed NCT03163498 - Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
Completed NCT04093271 - Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep Phase 1
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04120363 - Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations Phase 4